Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC
SUZHOU, China, Oct. 28, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted Fast Track Designation (FTD) by the U.S. Food and Drug...
Two Powerhouse Launches from Holistic Way Redefine Women's Wellness
Celebrating Beauty and Strength in Every Generation with Holistic Way's Bio-Elixir Rose Placenta® Collagen Shot and Premium Gold Bio-NMN Women SINGAPORE, May 13, 2025 /PRNewswire/ -- Holistic Way - Singapore's No. 1 health supplement brand and a...
Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward
GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias Perjos, President & CEO at Getinge. The...
